drugset / Trial / NCT03873298

Inhaled NO in IPF and COPD During 6 Minute Walk Test

NCT03873298

Phase 2 Unknown 100 enrolled Rabin Medical Center Bellerophon · collab
RandomizedParallel-groupSingle-blindTreatment

Summary

Our objective is to evaluate the influence of inhaled NO on the saturation and exercise capacity of patients with COPD and IPF. each participant will undergo two six minute walk tests, one with inhaled NO and the other with placebo.

Timeline

Start
2019-03-04
Primary completion
2020-03-04
Completion
2020-09-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Nitric Oxide Other / unclassified 45 ppm Inhaled
Subject Nitric Oxide Other / unclassified 75 ppm Inhaled
Subject Nitric Oxide Other / unclassified 115 ppm Inhaled